These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8575610)

  • 1. The modality of huoxue-huayu in treatment of retinal vein occlusion.
    Deng Y; Wang M; Duan J
    Yan Ke Xue Bao; 1995 Mar; 11(1):57-60. PubMed ID: 8575610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The modality of Huoxue-Huayu in treatment of retinal vein occlusion].
    Deng YP
    Zhonghua Yan Ke Za Zhi; 1993 Jan; 29(1):42-4. PubMed ID: 8334911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Huoxue Tongmai Lishui method on fundus fluorescein angiography of non-ischemic retinal vein occlusion: a randomized controlled trial].
    Peng QH; Yao XL; Zeng ZC; Su RB; Wei YP
    Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1035-41. PubMed ID: 19912734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
    Lahey JM; Fong DS; Kearney J
    Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of local ophthalmic artery fibrinolysis in severe forms of central retinal vein occlusion].
    Vallée JN; Aymard A; Paques M; Santiago PY; Gaudric A; Merland JJ
    J Radiol; 2001 Feb; 82(2):137-44. PubMed ID: 11428208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical observation of Dan-Hong Hua-Yu oral solution in treating retinal vein occlusion.
    Li TJ; Sun YC; Ma QY; Wu Y; Yang C; Zhang N; Yang Y; Yang YX
    Medicine (Baltimore); 2020 May; 99(21):e20173. PubMed ID: 32481287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
    Hattenbach LO; Friedrich Arndt C; Lerche R; Scharrer I; Baatz H; Margaron F; Richard G; Behrens-Baumann W; Ohrloff C
    Retina; 2009; 29(7):932-40. PubMed ID: 19584651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of huoxue-huayu in treating experimental intraocular hemorrhage by electroretinography].
    Duan JG; Deng YP
    Zhong Xi Yi Jie He Za Zhi; 1989 Oct; 9(10):609-12, 582. PubMed ID: 2605739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial thrombolysis for acute central retinal artery occlusion.
    Zhang X; Ji X; Luo Y; Liu D; Guo L; Wu H; Miao Z; Zhu F; Jiao L; Ding Y; Ling F
    Neurol Res; 2009 May; 31(4):385-9. PubMed ID: 19508824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sulodexide treatment in retinal vein obstructions].
    Corbu C; Predoi D; Goicea D
    Oftalmologia; 1996; 40(4):393-7. PubMed ID: 8962873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
    Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
    JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical treatment for experimental retinal vein occlusion--thrombolytic effect of nasaruplase].
    Suzuki Y; Matsumoto M; Katoh C; Mizutani H; Sakuraba T; Yoshimoto H
    Nippon Ganka Gakkai Zasshi; 1996 Jan; 100(1):27-33. PubMed ID: 8644523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated cannulation technique for tissue plasminogen activator injection into peripapillary retinal vein for central retinal vein occlusion.
    van Overdam KA; Missotten T; Spielberg LH
    Acta Ophthalmol; 2015 Dec; 93(8):739-44. PubMed ID: 26310993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal vein occlusion and the optic disk.
    Hayreh SS; Zimmerman MB; Podhajsky PA
    Retina; 2012; 32(10):2108-18. PubMed ID: 22914682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits.
    Ameri H; Kim JG; Ratanapakorn T; Chader GJ; Humayun MS
    Retina; 2008 Feb; 28(2):350-5. PubMed ID: 18301042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors, antithrombotic treatment and outcome in retinal vein occlusion: an age-related prospective cohort study.
    Sartori MT; Barbar S; Donà A; Piermarocchi S; Pilotto E; Saggiorato G; Prandoni P
    Eur J Haematol; 2013 May; 90(5):426-33. PubMed ID: 23461717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion.
    Jung SH; Kim KA; Sohn SW; Yang SJ
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2290-6. PubMed ID: 24398091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
    Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
    Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal ranibizumab for macular edema secondary to retinal vein occlusion.
    Kim M; Yu SY; Kim ES; Bae SH; Park JH; Yu HG; Kwak HW
    Ophthalmologica; 2012; 227(3):132-8. PubMed ID: 22212151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.